• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

BioCorp’s smart cap wins CE Mark for insulin pen

December 20, 2017 By Sarah Faulkner

BiocorpBiocorp (PAR:ALCOR) said today that its smart cap, Easylog, won CE Mark clearance for use with insulin delivery devices.

The company’s device turns traditional pen injectors into connected devices, capturing treatment information like dose, date and time of injection. Easylog transfers that data to a mobile app for patients to monitor.

“CE marking for Easylog is a significant step for Biocorp. Our ambition is to develop and market innovative devices boosting compliance, a key factor for the successful treatment of chronic conditions such as diabetes. Easylog device, which generates interest of many industrial players internationally, brings an extra dimension to the customization of treatments. We are particularly pleased to reach this milestone that confirms our pioneering position in the digitalization of drug delivery devices and will contribute to achieve our growth objectives,” chief operating officer Eric Dessertenne said in prepared remarks.

Biocorp reported that it plans to launch its Easylog product in the EU sometime in 2018 through the help of partnerships.

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Diabetes, Drug-Device Combinations, Featured, mHealth (Mobile Health), Patient Monitoring, Pharmaceuticals, Wall Street Beat Tagged With: biocorp

IN CASE YOU MISSED IT

  • Medtronic enrolls first patient in study for Onyx liquid embolic system
  • BD issues voluntary recall on certain Alaris infusion pump modules
  • Sequel Med Tech expects full twiist launch in the fall
  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS